Novo Nordisk announced its oral GLP-1 has been approved by the FDA to reduce risk for major adverse cardiovascular events in ...
“Elta MD is a huge favorite among dermatologists,” says Bank, who likes the brand’s UV Daily Broad Spectrum SPF 40 due to its ...
In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis ...
The drug, called Rybelsus, is the only oral GLP-1 medication available. It was previously approved to treat Type 2 diabetes ...
The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...
The British pharmaceutical giant has joined the direct-to-consumer push, following Pfizer and Amgen’s announcements in ...
Trump to announce new deal with AstraZeneca to lower prescription drug costs for Americans using most-favored-nation pricing ...
In REPO, there are many items you can buy that can affect your run. While you’ll want to get upgrades and health often, many other useful items can be purchased too. One of the more obscure items to ...
There couldn’t be a more pressing or galvanizing topic for Americans than the high cost of prescription drugs.
Trump’s focus on lowering drug prices targets a critical issue for Americans. But without far greater transparency, it’s ...
Amgen makes Repatha available through AmgenNow, a direct-to-patient programme in the US: Thousand Oaks, California Wednesday, October 8, 2025, 17:00 Hrs [IST] Amgen announced the ...
In today's Pharmalittle roundup, we're reading about Novo Nordisk layoffs, an Amgen discount program, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback